Bone-seeking radiopharmaceuticals in patients with skeletal metastases. Clinical experience using alpha-emitting radium-223

被引：0
|
作者：
Nilsson, S.
Larsen, R. H.
Bruland, O. S.
机构：
[1] Karolinska Hosp, S-10401 Stockholm, Sweden
[2] Algeta ASA, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 78卷
关键词：
D O I：
10.1016/S0167-8140(06)80562-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [21] Treatment of patients with castration-resistant prostate cancer and bone metastases with radium-223: A single institution experience
    Devarakonda, Srinivas S.
    Skweres, Justin
    Nair, Binu Sivaraman
    Dhawan, Manish
    Takalkar, Amol
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] MICRODISTRIBUTION OF ALPHA PARTICLE EMITTING RADIUM-223 DICHLORIDE IN MODELS OF PROSTATE CANCER BONE METASTASIS
    Abou, Diane
    Ulmert, David
    Hobbs, Robert
    Riddle, Ryan
    Thorek, Daniel
    JOURNAL OF UROLOGY, 2015, 193 (04): : E551 - E551
  • [23] Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
    Kapoor, Anil
    Wong, Nathan C.
    Wang, Yuding
    Mukherjee, Som
    Hotte, Sebastien
    Dayes, Ian
    Lukka, Himu
    ASIAN JOURNAL OF ANDROLOGY, 2020, 22 (04) : 437 - 438
  • [24] Radium-223 chloride, a first-in-class alpha-pharmaceutical for patients with castration resistant prostate cancer (CRPC) and bone metastases. Dosimetry and pharmacokinetic analysis
    Lewington, Valerie
    Parker, Chris
    Hindorf, Cecilia
    Flux, Glenn
    Chittenden, Sarah
    Sgouros, George
    O'Bryan-Tear, Gillies
    Aksnes, Anne-Kirsti
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [25] Radium-223 Chloride: Extending Life in Prostate Cancer Patients by Treating Bone Metastases
    Wissing, Michel D.
    van Leeuwen, Fijs W. B.
    van der Pluijm, Gabri
    Gelderblom, Hans
    CLINICAL CANCER RESEARCH, 2013, 19 (21) : 5822 - 5827
  • [26] Significant antitumor effect from bone-seeking, α-particle-emitting 223Ra demonstrated in an experimental skeletal metastases model
    Henriksen, G
    Breistol, K
    Bruland, OS
    Fodstad, O
    Larsen, RH
    CANCER RESEARCH, 2002, 62 (11) : 3120 - 3125
  • [27] Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
    Pacilio, Massimiliano
    Ventroni, Guido
    De Vincentis, Giuseppe
    Cassano, Bartolomeo
    Pellegrini, Rosanna
    Di Castro, Elisabetta
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Garkavaya, Tatiana
    Lorenzon, Leda
    Ialongo, Pasquale
    Pani, Roberto
    Mango, Lucio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 21 - 33
  • [28] Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
    Massimiliano Pacilio
    Guido Ventroni
    Giuseppe De Vincentis
    Bartolomeo Cassano
    Rosanna Pellegrini
    Elisabetta Di Castro
    Viviana Frantellizzi
    Giulia Anna Follacchio
    Tatiana Garkavaya
    Leda Lorenzon
    Pasquale Ialongo
    Roberto Pani
    Lucio Mango
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 21 - 33
  • [29] Targeted bone-seeking radiopharmaceuticals for the palliation of bone pain from skeletal metastases: a systematic review and meta-analysis
    D'Angelo, G.
    Bernardo, G.
    Bordonaro, R.
    Condemi, G.
    Mantini, G.
    Mazzarotto, R.
    Monari, F.
    Sperduti, I.
    Salvatori, M.
    Sciuto, R.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S293 - S293
  • [30] The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience
    De Luca, Rossella
    Costa, Renato Patrizio
    Tripoli, Vincenzo
    Murabito, Alessandra
    Cicero, Giuseppe
    ONCOLOGY, 2018, 94 (03) : 161 - 166
12345